The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
On-Demand Educational Webinars
Supply chain leaders share their processes and experiences in managing non-labor and non-personnel expenses.
On-Demand Educational Webinars
Provider panelists discuss their post-pandemic approach to their business continuity programs, working with non-traditional buyers, diversifying…
Podcasts
Michael Brown, Director of Supply Chain Management and Eric Swaim, Manager of Strategic Sourcing and Vendor Management at Texas Children’s Hospital…
On-Demand Educational Webinars
Listen as distributor and manufacturer panelists discuss their changing strategies relating to COVID-19 lessons, domestic verses international…
Webcast
Dr. Randy Bradley discusses the attributes leaders must have in order to be effective when managing a multi-generational workforce.
Webcast
Karen Conway, Vice President, Healthcare Value at GHX and Mike Schiller, Senior Director of Supply Chain at AHRMM discuss the value of UDI beyond r